Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Previous western studies have found Caucasians with skin cancer, either melanoma or nonmelanoma skin cancer (NMSC), have an elevated risk of second primary cancer. Our objective was to assess the risk of second primary cancer in Taiwanese with NMSC. Materials and Methods By using data from Taiwan’s National Health Insurance Research Database, we conducted a population-based cohort study to assess the risk of incident second primary cancer in Taiwanese affected by NMSC. Results We identified 505 subjects with NMSC and 2,020 matched controls. After adjustment for potential confounders including age, sex, urbanization, and Charlson Comorbidity Index, people who had NMSC had a 1.43-fold (95% confidence interval [CI], 1.05 to 1.96) risk for the development of second primary cancer as compared with control group. Men with NMSC had a 2.99-fold (95% CI, 1.00 to 9.10) risk for second primary cancer involving the lip, oral cavity, and pharynx and a 3.51-fold (95% CI, 1.21 to 10.17) risk for second primary cancer involving the genitourinary organs when compared to the control group. By contrast, women with NMSC did not have an increased risk of second primary cancer. Conclusion This study revealed Asians with NMSC have an increased risk of second primary cancer. Our findings can be a useful reference for health care for people diagnosed with NMSC.
Abstract
Purpose Previous western studies have found Caucasians with skin cancer, either melanoma or nonmelanoma skin cancer (NMSC), have an elevated risk of second primary cancer. Our objective was to assess the risk of second primary cancer in Taiwanese with NMSC. Materials and Methods By using data from Taiwan’s National Health Insurance Research Database, we conducted a population-based cohort study to assess the risk of incident second primary cancer in Taiwanese affected by NMSC. Results We identified 505 subjects with NMSC and 2,020 matched controls. After adjustment for potential confounders including age, sex, urbanization, and Charlson Comorbidity Index, people who had NMSC had a 1.43-fold (95% confidence interval [CI], 1.05 to 1.96) risk for the development of second primary cancer as compared with control group. Men with NMSC had a 2.99-fold (95% CI, 1.00 to 9.10) risk for second primary cancer involving the lip, oral cavity, and pharynx and a 3.51-fold (95% CI, 1.21 to 10.17) risk for second primary cancer involving the genitourinary organs when compared to the control group. By contrast, women with NMSC did not have an increased risk of second primary cancer. Conclusion This study revealed Asians with NMSC have an increased risk of second primary cancer. Our findings can be a useful reference for health care for people diagnosed with NMSC.
참고문헌 (22)
- Chuang SC, "Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries", Cancer Epidemiol Biomarkers Prev, 17, pp.1543~1549 (2008)[DOI]
- Chuang SC, "Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries", Int J Cancer, 123, pp.2390~2396 (2008)[DOI]
- Robsahm TE, "New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway", BMC Cancer, 14, pp.210~ (2014)[DOI]
- Song F, "Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study", PLoS Med, 10, pp.e1001433~ (2013)[DOI]
- Levi F, "Risk of prostate, breast and colorectal cancer after skin cancer diagnosis", Int J Cancer, 123, pp.2899~2901 (2008)[DOI]
- Soerjomataram I, "Are patients with skin cancer at lower risk of developing colorectal or breast cancer?", Am J Epidemiol, 167, pp.1421~1429 (2008)[DOI]
- Hwang CY, "Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan", J Dermatol Sci, 60, pp.167~172 (2010)[DOI]
- Cheng CL, "Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan", Pharmacoepidemiol Drug Saf, 20, pp.236~242 (2011)[DOI]
- Wu CS, "Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan", PLoS One, 9, pp.e112257~ (2014)[DOI]
- Hsing AW, "Nationwide population science: lessons from the Taiwan National Health Insurance Research Database", JAMA Intern Med, 175, pp.1527~1529 (2015)[DOI]
- [URL]
- D'Agostino RB Jr, "Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group", Stat Med, 17, pp.2265~2281 (1998)[DOI]
- Jung GW, "Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009", Br J Dermatol, 170, pp.136~143 (2014)[DOI]
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation", J Chronic Dis, 40, pp.373~383 (1987)[DOI]
- Li B, "Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases", BMC Health Serv Res, 8, pp.12~ (2008)[DOI]
- Satagopan JM, "A note on competing risks in survival data analysis", Br J Cancer, 91, pp.1229~1235 (2004)[DOI]
- Efird JT, "Risk of subsequent cancer following invasive or in situ squamous cell skin cancer", Ann Epidemiol, 12, pp.469~475 (2002)[DOI]
- Bower CP, "Basal cell carcinoma and risk of subsequent malignancies: a cancer registry-based study in southwest England", J Am Acad Dermatol, 42, pp.988~991 (2000)[DOI]
- Rosenberg CA, "Association of nonmelanoma skin cancer with second malignancy", Cancer, 100, pp.130~138 (2004)[DOI]
- Chuang YC, "Gender differences in relationships between social capital and individual smoking and drinking behavior in Taiwan", Soc Sci Med, 67, pp.1321~1330 (2008)[DOI]
- Zeegers MP, "Elevated risk of cancer of the urinary tract for alcohol drinkers: a meta-analysis", Cancer Causes Control, 10, pp.445~451 (1999)[DOI]
- Jemal A, "Global patterns of cancer incidence and mortality rates and trends", Cancer Epidemiol Biomarkers Prev, 19, pp.1893~1907 (2010)[DOI]
